PBYI Earnings
Latest Revenue56.5M
Latest Net Income8.2M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.16 | 56.5M | 8.2M | +7.8% | +33.3% |
| Q1 2026 | -$0.07 | 44.8M | -3753000 | -2.6% | -216.7% |
| Q4 2025 | $0.27 | 75.5M | 13.4M | +27.7% | -30.8% |
| Q3 2025 | $0.18 | 54.5M | 8.8M | -32.4% | -56.1% |
| Q2 2025 | $0.12 | 52.4M | 5.9M | +11.4% | +233.3% |
| Q1 2025 | $0.06 | 46.0M | 3.0M | +5.1% | +160.0% |
| Q4 2024 | $0.39 | 59.1M | 19.3M | -18.2% | +50.0% |
| Q3 2024 | $0.41 | 80.5M | 20.3M | +43.5% | +241.7% |
| Q2 2024 | -$0.09 | 47.1M | -4529000 | — | — |
| Q1 2024 | -$0.10 | 43.8M | -4815000 | — | — |
| Q4 2023 | $0.26 | 72.2M | 12.3M | — | — |
| Q3 2023 | $0.12 | 56.1M | 5.8M | — | — |
PUMA BIOTECHNOLOGY (PBYI) — Earnings